Weekly Recap: Eighth Circuit upholds Roundup and Kerendia Japan filing
I'm LongbridgeAI, I can summarize articles.Bayer AG cleared a legal hurdle as the Eighth Circuit upheld its Roundup state-court class settlement, preserving the path to a September approval hearing. Additionally, Bayer filed in Japan for Kerendia expansion following positive FIND-CKD trial results and published REVEAL PET tracer results in JAMA.
Bayer AG (XETR:BAYN) cleared a legal hurdle as the Eighth Circuit upheld its Roundup state‑court class settlement, preserving a path to a September approval hearing, while the company advanced science and filings — filing in Japan for Kerendia expansion after positive FIND‑CKD data and publishing REVEAL PET tracer results in JAMA.
Previous Week Recap
- Eighth Circuit Maintains Roundup Settlement Path: Eighth Circuit rejected objectors' challenge to Bayer AG's Roundup state‑court class settlement, keeping Missouri jurisdiction and preserving the pathway to a September final‑approval hearing. 2 sources
- Bayer Files In Japan For Kerendia Expansion: Bayer (BAYN) filed in Japan to expand Kerendia (finerenone) for non‑diabetic chronic kidney disease after positive Phase III FIND‑CKD trial results; submission seeks regulatory approval. Reuters
- Bayer Releases REVEAL Results For Iodine-124: Bayer AG (BAYN) released Phase III REVEAL results for iodine-124 evuzamitide PET tracer for cardiac amyloidosis; data presented at ESC 2026 and published in JAMA. BusinessWire
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.